Subcommittee chairman Bart Stupak said

Subcommittee chairman Bart Stupak said,’If we do not some rapid progress on fixing the foreign drug inspection program . The next heparin tragedy will soon be upon us ‘(AP / Chicago Tribune.

Marcia Crosse, the GAO said, ‘With the growth in foreign drug manufacturing for the U.S. Market and the current large gaps in foreign drug FDA inspections, FDA will need to devote significant resources in this area, when. At the rate of increase inspections ‘It added ‘FDA currently plans for incremental increases that in the near term in the near future.

Of the of lens StorageWorks Case of refractive surgery candidates.